Posted on

Extra Crunch roundup: Digital health VC survey, edtech M&A, deep tech marketing, more

I had my first telehealth consultation last year, and there’s a high probability that you did, too. Since the pandemic began, consumer adoption of remote healthcare has increased 300%.
Speaking as an unvaccinated urban dweller: I’d rather speak to a nurse or doctor via my laptop than try to remain physically distanced on a bus or hailed ride traveling to/from their office.
Even after things return to (rolls eyes) normal, if I thought there was a reliable way to receive high-quality healthcare in my living room, I’d choose it.
Clearly, I’m not alone: a May 2020 McKinsey …

Read More

Posted on

End-to-end operators are the next generation of consumer business

Roger Lee
Contributor

Roger Lee is a general partner at Battery Ventures, based in Menlo Park, CA, who focuses on investments in software and consumer tech, including online marketplaces.

More posts by this contributor

Keys to ascending the consumer-internet throne
How to communicate with your board in tough times

Justin Da Rosa
Contributor

Justin Da Rosa is a vice president with Battery Ventures in San Francisco. He focuses on consumer internet, online marketplace and software investments.

More posts by this contributor

Five success factors for behavioral health startups

At Battery, a central part of our consumer investing practice involves tracking …

Read More

Posted on

Hims, the telehealth startup, saw its shares slip in their trading debut — and that’s fine with its CEO

Hims & Hers, a San Francisco-based telehealth startup that sells sexual wellness and other health products and services to millennials, began trading publicly today on the NYSE after completing a reverse merger with the blank-check company Oaktree Acquisition Corp.
Its shares slipped a bit, ending the day down 5% from where they started, but the company, which was founded in 2017 and now claims nearly 300,000 paying subscribers for its various offerings, has never been focused on a splashy headline about its first-day performance, co-founder and CEO Andrew Dudum told us earlier today.
On the contrary, Dudum says that while Hims might have once …

Read More

Posted on

It may not be as glamorous as D2C, but beauty tech is big money

Sindhya Valloppillil
Contributor

Sindhya Valloppillil is the founder and CEO of Skin Dossier, a venture partner at Next Gen Ventures, a freelance writer and formerly a beauty industry executive and marketing professor.

Last week, Procter & Gamble (P&G) announced that it was terminating plans to acquire razor startup Billie following a U.S. Federal Trade Commission lawsuit to stop the deal.
Last year, Edgewell Personal Care ditched its debt-heavy $1.37 billion deal for Harry’s, Inc, formerly valued at $1 billion after the FTC sought to block the acquisition.
In addition to these FTC challenges, it is also now becoming clear that …

Read More

Posted on

Flo gets FTC slap for sharing user data when it promised privacy

The FTC has reached a settlement with Flo, a period- and fertility tracking app with 100M+ users, over allegations it shared users’ health data with third party app analytics and marketing services like Facebook despite promising to keep users’ sensitive health data private.
Flo must obtain an independent review of its privacy practices and obtain app users’ consent before sharing their health information, under the terms of the proposed settlement.
The action follows a 2019 reports in the Wall Street Journal which conducted an analysis of a number of apps’ data sharing activity.
It found the fertility tracking app had informed …

Read More

Posted on

Kyrgyzstan Awaits Russian Permit for Deliveries of Sputnik V Vaccine

Kyrgyzstan, having submitted a request to obtain the Russian Sputnik V vaccine against the coronavirus, awaits a permit from Russian authorities to deliver it to the republic, Kyrgyz Health Minister Alymkadyr Beishenaliev told TASS on Sunday.
“We sent a letter signed by acting President Mamytov to Russian President Vladimir Putin,” the minister noted, adding that he discussed this issue with his Russian counterpart Mikhail Murashko.

Earlier, the Kyrgyz Health Minister reported that in the near future the Central Asian republic intends to send to Russia a request for 500,000 doses of the Sputnik V vaccine. Additionally, according to him, the sides …

Read More

Posted on

Endeavor BioMedicines raises $62 million to combat pulmonary disease

A new startup has officially emerged for stealth with the raise of its $62 million Series A funding round. Endeavor BioMedicines is led by co-founder and CEO John Hood, who previously led Impact Biomedicines, and its new funding comes from Omega Funds and Longitude Capital, as well as the company’s own management team. Endeavor is also co-founded by Miguel de los Rios, who serves as its Chief Science Officer and who was previously CEO of Rift Biotherapeutics.
Endeavor’s goal is to develop treatments specifically to address pulmonary disease, and the startup is putting its funding towards two Phase 2 clinical …

Read More

Posted on

Sources: Hinge Health has raised $310M Series D at a $3B valuation

Hinge Health, the San Francisco-based company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions — such as back and joint pain — has closed a $310 million in Series D funding, according to sources.
The round is led by Coatue and Tiger Global, and values 2015-founded Hinge at $3 billion post-money, people familiar with the investment tell me. It comes off the back of a 300% increase in revenue in 2020, with investors told to expect revenue to nearly triple again in 2021 based on the company’s booked pipeline.
I also understand that Hinge’s founders — Daniel Perez and Gabriel Mecklenburg — retain voting …

Read More